Cargando…
Association of Apelin and Apelin Receptor Polymorphisms With the Risk of Comorbid Depression and Anxiety in Coronary Heart Disease Patients
The Apelin (APLN)/apelin receptor (APLNR) signaling pathway is a newly identified regulator in various cardiovascular diseases, which is considered as a candidate pathway for the occurrence of coronary heart disease (CHD), depression, and anxiety. The goal of this study was to investigate the associ...
Autores principales: | Wang, Ying, Liu, Wenhui, Xiao, Yiwen, Yuan, Haiyan, Wang, Feng, Jiang, Pei, Luo, Zhiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432257/ https://www.ncbi.nlm.nih.gov/pubmed/32849850 http://dx.doi.org/10.3389/fgene.2020.00893 |
Ejemplares similares
-
On Methods for the Measurement of the Apelin Receptor Ligand Apelin
por: Janssens, Peter, et al.
Publicado: (2022) -
Apelin and apelin receptor expression in renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2019) -
The Effects of Apelin and Elabela Ligands on Apelin Receptor Distinct Signaling Profiles
por: Jiang, Yunlu, et al.
Publicado: (2021) -
Temporal Expression of Apelin/Apelin Receptor in Ischemic Stroke and its Therapeutic Potential
por: Wu, Yili, et al.
Publicado: (2017) -
Association of apelin and apelin receptor with the risk of coronary artery disease: a meta-analysis of observational studies
por: Chen, Tianbao, et al.
Publicado: (2017)